BIZTRAC BETA
Retail sale of pharmaceutical products

NEDENES APOTEK AS

Org. no. 924630000 Limited company (AS) Arendal Incorporated 2020 Active
Ownership graph ↗
Revenue 2025 NOK 26.9m
Operating profit NOK 1.7m
Equity NOK 377,000
Incorporated 2020
Employees 12
Share capital NOK 30,000

Signals

1 flags
  • Ingen revisor Selskapet har ingen registrert revisor. Vanlig for små AS som har valgt bort revisjon, men verdt å merke seg.

NEDENES APOTEK AS is registered as a limited company in Arendal, Agder with organisation number 924630000. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2020 and has 12 registered employees. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Eie og drive apotek og handel med apotekvarer.”. The most recent filed accounts, for the 2025 financial year, show NOK 26.9m in revenue and NOK 1.7m in operating profit.

Key figures · 2025

Revenue
NOK 26.9m
Operating profit
NOK 1.7m
Equity
NOK 377,000
Est. value
NOK 7.0m

Financial health · 2025

Liquidity
1.04
Satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
6.8%
Weak
Equity as a share of total capital

Who owns NEDENES APOTEK AS?

SØR PHARMA INVEST AS
NEDENES APOTEK AS
NOK 26.9m rev. · NOK 1.7m profit

NEDENES APOTEK AS has 3 registered shareholders:

All shareholders and roles →

Frequently asked questions about NEDENES APOTEK AS

Who owns NEDENES APOTEK AS?

SØR PHARMA INVEST AS is the largest registered owner, with 51.0%.

What is the revenue of NEDENES APOTEK AS?

NEDENES APOTEK AS had revenue of NOK 26.9m in 2025.

Who is the general manager of NEDENES APOTEK AS?

Mohamad Karouni is registered as general manager of NEDENES APOTEK AS.

Where is NEDENES APOTEK AS based?

NEDENES APOTEK AS has its business address in Nedenes.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.